Carbamazepine · more major-labeled pairs than Buprenorphine/Naloxone
SPL labels Buprenorphine/Naloxone + Carbamazepine as minor; Buprenorphine/Naloxone 19 / Carbamazepine 110 in that band.
Mechanism on file: Carbamazepine speeds up how quickly your body gets rid of buprenorphine, which can make the treatment less effective.
FDA SPL severity: Minor
Buprenorphine/Naloxone + Carbamazepine · SPL mechanism field
Carbamazepine speeds up how quickly your body gets rid of buprenorphine, which can make the treatment less effective.
Minor band excerpt · Buprenorphine/Naloxone with Carbamazepine
Examples: Rifampin, carbamazepine, phenytoin Antiretrovirals: Non-nucleoside reverse transcriptase inhibitors (NNRTIs) Clinical Impact: Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are metabolized principally by CYP3A4.
Buprenorphine/Naloxone · 19 minor + 19 total pairs
- Buprenorphine minor
- Cyclobenzaprine minor
- Darunavir minor
- Erythromycin minor
Carbamazepine · 3 major-labeled pairs (vs Buprenorphine/Naloxone's 0)
- Acetaminophen minor
- Acetaminophen/Oxycodone minor
- Albendazole minor
- Alprazolam minor
FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.
Read our methodology - how this data is sourced, computed, and verified.